Key facts
- Creda’s last known valuation is $22.0M (Jan 2026).
- It has raised $6.3M; the latest was Seed Round ($1.3M) in Jan 2026.
- Notable investors include Innospark Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Creda
- ·The full record, as it builds
Funding rounds
No funding rounds for Creda are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Creda
Developer of a chronic condition management application designed to address the critical care gap. The company's technology intelligently engages both the patients and providers for goal-oriented outcomes in a personalized manner and has leveraged artificial intelligence and machine learning, it Identifies patterns and triggers related to conditions like- diabetes, hypertension, lupus, including outbreaks, seasonal effects, diet, and much more, enabling users to get reliable, comprehensive information about health condition with expert guidance to address potential complications early on.
- Sector
- Healthcare
- HQ
- Norwood, MA, United States
- Founded
- 2017
- Employees
- 6
- Website
- credahealth.com/
- Ownership
- Privately Held (backing)
Creda doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Creda shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Creda in its N-PORT filings yet. We sweep new filings monthly.